Patent 7361734 was granted and assigned to Smithkline Beecham Limited on April, 2008 by the United States Patent and Trademark Office.
A Staphylococcus aureus S8 native crystalline structure and a Staphylococcus aureus S8 mode of binding with rRNA were identified.